The Department of Neurological Sciences at Rush University Medical Center is participating in a study looking at the effects of coenzyme Q10 on the progression of functional decline in Huntington's disease, as well as the long-term safety and tolerability of the study dosage.
You may be eligible to participate in this study if you are 16 years of age or older, have early (mild to moderate) Huntington's disease, can walk independently and are fully-self-sufficient in activities of daily living.
This is a partial list of eligibility and exclusion criteria. For more information, call the contact number provided. If you wish to inquire via email, please refer to the study title in your message.